
Indian biotech companies actively developing mRNA-based vaccines, therapeutics: DBT
New Delhi, May 17 (IANS) The Indian biotech companies are actively developing mRNA-based vaccines and therapeutics, said a team of scientists at the Department of Biotechnology (DBT), under the Ministry of Science and Technology.They were speaking at the 14th Webinar under the ‘Webinar Series on Biofoundry and Biomanufacturing Initiative’, along with Biotechnology Industry Research Assistance Council (BIRAC).The session focused on “Biomanufacturing for mRNA Therapeutics”, a vital component under the BioE3 (Biotechnology for Economy, Environment and Employment) Policy.“The BioE3 Policy’s vision is to foster high-performance biomanufacturing by supporting sustainable green growth. This approach marks a global shift toward sustainability, fuelling a ‘BioRevolution’ with the potential to resha...